Surgical Care Affiliates, a subsidiary of UnitedHealth Group, was indicted this week by a federal grand jury on charges that it entered agreements with competitors to not poach executives.
The Department of Justice (DOJ) alleges that the company, which operates outpatient medical centers, engaged in “two bilateral conspiracies” with other healthcare companies that aimed to avoid competition between them for senior executives, which violates the Sherman Act.
One agreement lasted from as early as May 2010 through October 2017, and the second lasted from February 2012 to July 2017, the DOJ said. UnitedHealth acquired Surgical Care Affiliates in 2017, and it is now a part of Optum.
“The charges demonstrate the Antitrust Division’s continued commitment to criminally prosecute collusion in America’s labor markets,” said Assistant Attorney General Makan Delrahim of the DOJ’s Antitrust Division in a statement.
“A freely competitive employment market is essential to the health of our economy and the mobility of American workers. Along with our law enforcement partners, the division will ensure that companies who illegally deprive employees of competitive opportunities are not immune from our antitrust laws,” Delrahim said.
Read More: No Poaching Agreements and Antitrust Enforcement
The DOJ said these charges are the first in an ongoing investigation. A Sherman Act violation carries a maximum penalty of $100 million to companies.
In a statement (PDF), Surgical Care Affiliates said it rejects the charges, as the government is applying antitrust laws in a way for which “there is no president or foundation.”
“This matter involves alleged conduct seven years before UnitedHealth Group acquired SCA and does not involve any SCA ambulatory surgery centers, their joint owners, physician partners, current leadership or any other UnitedHealth Group companies. SCA disagrees with the government’s position and will vigorously defend itself against these unjustified allegations,” Surgical Care Affiliates said.
“SCA takes its legal responsibilities seriously and works every day to ensure compliance with applicable laws,” the company said.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Clifford Chance Expands Global Antitrust Team with New Partner
Dec 6, 2024 by
CPI
Spain’s Financial Regulator Awaits Antitrust Decision on BBVA’s Hostile Bid for Sabadell
Dec 5, 2024 by
CPI
RealPage Seeks Dismissal of DOJ Antitrust Suit, Citing Legal Flaws
Dec 5, 2024 by
CPI
EU Competition Chief Signals Potential Google Breakup Amid Big Tech Scrutiny
Dec 5, 2024 by
CPI
Turkey Closes Antitrust Probe into Meta’s Threads-Instagram Practices
Dec 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI
Assessing the Potential for Antitrust Moats and Trenches in the Generative AI Industry
Nov 29, 2024 by
Allison Holt, Sushrut Jain & Ashley Zhou
How SEP Hold-up Can Lead to Entrenchment
Nov 29, 2024 by
Jay Jurata, Elena Kamenir & Christie Boyden
The Role of Moats in Unlocking Economic Growth
Nov 29, 2024 by
CPI
Overcoming Moats and Entrenchment: Disruptive Innovation in Generative AI May Be More Successful than Regulation
Nov 29, 2024 by
Simon Chisholm & Charlie Whitehead